✦ LIBER ✦

Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer

✍ Scribed by Robyn L Ward; Nicholas J Hawkins; David Coomber; Mary L Disis

Book ID: 117415844
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 198 KB
Volume: 60
Category: Article
ISSN: 0198-8859
DOI: 10.1016/s0198-8859(99)00003-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pre-existent immunity to the HER-2/neu o

Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer

✍ Mary L. Disis; Keith L. Knutson; Kathy Schiffman; Kristine Rinn; Douglas G. McNe 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 77 KB

Protein vaccination with the HER2/neu ex

Protein vaccination with the HER2/neu extracellular domain plus anti-HER2/neu antibody–cytokine fusion proteins induces a protective anti-HER2/neu immune response in mice

✍ Jay S.Dela Cruz; Suk Ying Lau; Ernesto M Ramirez; Carla De Giovanni; Guido Forni 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Humoral Epitope-Spreading Following Immu

Humoral Epitope-Spreading Following Immunization with a HER-2/neu Peptide Based Vaccine in Cancer Patients

✍ Mary L. Disis; Vivian Goodell; Kathy Schiffman; Keith L. Knutson 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 178 KB

A phase I study of a HER2/neu bispecific

A phase I study of a HER2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast cancer that overexpresses HER2/neu

✍ V. Pullarkat; Y. Deo; J. Link; L. Spears; V. Marty; R. Curnow; S. Groshen; C. Ge 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 365 KB

A virosomal formulated Her-2/neu multi-p

A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study

✍ Ursula Wiedermann; C. Wiltschke; J. Jasinska; M. Kundi; R. Zurbriggen; E. Garner 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 321 KB

c-erbB-2 (HER-2/neu) protein and drug re

c-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy

✍ Laura M. Vargas-Roig; Francisco E. Gago; Olga Tello; María T. Martin de Civetta; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 71 KB 👁 2 views

Expression of c-erbB-2 protein has been associated with poor prognosis and poor response to chemotherapy in breast cancer patients. In the present prospective study, we have analyzed whether c-erbB-2, p53 and P170 proteins may be determinants of tumor resistance in locally advanced breast cancer pat